No more delays: Get Enhertu for patients with HER2-low metastatic breast cancer in Wales
Open for signatures until 31 October 2026.
799 signatures
- More than 250 signatures: considered by the Petitions CommitteeReached
- More than 10,000 signatures: considered for a debate in the SeneddNot reached
Enhertu is a treatment that can give people with metastatic HER2-low breast cancer more time. It is available to eligible patients in England and has been available in Scotland since 2023, but people in Wales are still waiting. Access to treatment should not depend on which side of the border someone lives. We are calling for access through NHS Wales and a clear timetable for its delivery.
More details
The tens of thousands of pounds raised by SheUltra Cymru for Breast Cancer Now supports research at Cardiff University's European Cancer Stem Cell Research Institute. The project is investigating making triple-negative breast cancer more sensitive to chemotherapy. This is a different type of breast cancer to the low-HER2 cancer targeted by Enhertu, but it shows Wales' important contribution to breast cancer research. It doesn't make sense that important research is taking place in Wales while eligible patients here are waiting for treatment available across the border.
I'm Huw Williams, founder of SheUltra Cymru, the world's largest women-only ultramarathon. I live with stage four inoperable neuroendocrine cancer, so I know what the hope of having more time means for patients and their families.
England and Scotland have acted. Wales must be next.
Signatures by constituency
The Senedd's petitions website lists 619 of the 799 signatures under a Senedd constituency.
| Constituency | Signatures |
|---|---|
| Fflint Wrecsam | 225 |
| Gwynedd Maldwyn | 221 |
| Clwyd | 48 |
| Bangor Conwy Môn | 33 |
| Caerdydd Penarth | 21 |
| Pen-y-bont Bro Morgannwg | 19 |
| Pontypridd Cynon Merthyr |